US medical technology firm Recovery Force has received a $1.8m grant from the US National Institutes of Health to develop and clinically validate a device that aims to prevent occurrence of
We are pleased to invite you to the Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, scheduled for June 5-6, 2019, in Berlin, Germany.
We are pleased to invite you to the 4th Annual Antibody Drug Conjugates Summit: From Target to Therapeutics scheduled for May 15-16, 2019 in Vienna, Austria.
